2 recruiting, 1 completed. 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Recruiting 2, Completed 1 |
Follow Gemcitabine alone: new trials by email Literature Review of Gemcitabine alone trials Research Report on Gemcitabine alone
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Tepotinib vs Standard Treatment in Patients With Advanced MET Exon 14 Mutated Non-Small Cell Lung Cancer Previously Treated Tepotinib, Pemetrexed (Alimta), Vinorelbine - Advanced Non Small Cell Lung Cancer, MET Exon 14 Mutation | Phase 3 | Recruiting | Intergroupe Francophone de Cancerologie Thoracique | 133 | 2025-12-09 | 2025-12-17 |
| A Phase III Study With THIO + Cemiplimab vs Chemotherapy as 3rd Line Treatment in Advanced/Metastatic NSCLC 6-Thio-2'-Deoxyguanosine, Cemiplimab, Docetaxel - Carcinoma, Non-Small -Cell Lung | Phase 3 | Recruiting | Maia Biotechnology | 300 | 2025-12-08 | 2026-01-12 |
| Gemcitabine With or Without Capecitabine in Treating Patients With Advanced Pancreatic Cancer Gemcitabine + Capecitabine, Gemcitabine alone - Pancreatic Cancer | Phase 3 | Completed | Swiss Cancer Institute | 319 | 2001-06-01 | 2019-05-15 |
Carcinoma, Non-Small-Cell Lung (2) · Adenocarcinoma (1) · Carcinoma, Large Cell (1) · Carcinoma, Squamous Cell (1) · Pancreatic Neoplasms (1)
Intergroupe Francophone de Cancerologie Thoracique (1) · Maia Biotechnology (1) · Swiss Cancer Institute (1)
Austria (1) · France (1) · Israel (1) · Italy (1) · Poland (1) · Romania (1) · Switzerland (1) · Taiwan (1) · Turkey (Türkiye) (1)
Richard Herrmann, MD (1) · Victor Zaporojan, Medical Doctor (1) · Werner Scheithauer, MD (1)
PMID 17538165, PMID 18249033, PMID 18669454, PMID 20877359, PMID 30636977